Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1942 Target Snapshot

Alpha-2B adrenergic receptor · SINGLE PROTEIN · Homo sapiens

2,726Compounds
325Assays
186Approved Drugs
2,613.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P18089. Use UniProt P18089 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P18089 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Alpha-2B adrenergic receptor as ChEMBL target CHEMBL1942, mapped to UniProt P18089. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Alpha-2B adrenergic receptor
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL1942
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P18089
Alpha-2B adrenergic receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Alpha-2B adrenergic receptor is the right protein anchor across sources, using UniProt P18089 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAlpha-2B adrenergic receptor
UniProt AccessionP18089
Component TypeProtein
Sequence Length450 aa

Alpha-2B adrenergic receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Alpha-2B adrenergic receptor, mapped to UniProt P18089. Sequence length is 450 aa.

Mapped IDP18089
Review nameAlpha-2B adrenergic receptor
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

186
Approved
23
Phase III
32
Phase II
4
Phase I
Assay Mix

Activity Type Distribution

IC50918.0
KI1,584.0
EC50110.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1256414 9.96 Ki 0.1096 Preclinical
CHEMBL1255723 9.74 Ki 0.182 Preclinical
CHEMBL1256378 9.69 Ki 0.2042 Preclinical
CHEMBL157138 9.62 Ki 0.237 Clinical
CHEMBL5517941 9.6 Ki 0.2512 Preclinical
CHEMBL1255724 9.46 Ki 0.3467 Preclinical
CHEMBL196 9.3 EC50 0.5 Approved
CHEMBL157138 9.29 IC50 0.518 Clinical
CHEMBL1256609 9.16 Ki 0.6918 Preclinical
CHEMBL1909072 9.11 Ki 0.786 Approved
Distribution

pChEMBL Value Distribution

106
5.0
195
5.5
255
6.0
126
6.5
87
7.0
98
7.5
51
8.0
34
8.5
7
9.0
7
9.5
pChEMBL
Approved Drugs

Approved Drugs

LOFEXIDINE
CHEMBL17860
Approved 2018
BREXPIPRAZOLE
CHEMBL2105760
Approved 2015
SILODOSIN
CHEMBL24778
Approved 2008
PALIPERIDONE
CHEMBL1621
Approved 2006
ARIPIPRAZOLE
CHEMBL1112
Approved 2002
DESLORATADINE
CHEMBL1172
Approved 2001
APOMORPHINE
CHEMBL53
Approved 2001
DEXMEDETOMIDINE HYDROCHLORIDE
CHEMBL2106195
Approved 1999
KETOTIFEN
CHEMBL534
Approved 1999
KETOTIFEN FUMARATE
CHEMBL1633
Approved 1999
DEXMEDETOMIDINE
CHEMBL778
Approved 1999
RABEPRAZOLE
CHEMBL1219
Approved 1999
CELECOXIB
CHEMBL118
Approved 1998
PRAMIPEXOLE
CHEMBL301265
Approved 1997
QUETIAPINE
CHEMBL716
Approved 1997
AZELASTINE HYDROCHLORIDE
CHEMBL1200809
Approved 1996
MIRTAZAPINE
CHEMBL654
Approved 1996
OLANZAPINE
CHEMBL715
Approved 1996
BRIMONIDINE
CHEMBL844
Approved 1996
CARVEDILOL
CHEMBL723
Approved 1995
NEFAZODONE HYDROCHLORIDE
CHEMBL1200492
Approved 1994
CISAPRIDE
CHEMBL1729
Approved 1993
RISPERIDONE
CHEMBL85
Approved 1993
SERTRALINE
CHEMBL809
Approved 1991
TICLOPIDINE
CHEMBL833
Approved 1991
DAPIPRAZOLE
CHEMBL1201216
Approved 1990
EBASTINE
CHEMBL305660
Approved 1990
SELEGILINE
CHEMBL972
Approved 1989
CLOMIPRAMINE
CHEMBL415
Approved 1989
CLOZAPINE
CHEMBL42
Approved 1989
PERGOLIDE
CHEMBL531
Approved 1988
RILMENIDINE
CHEMBL289480
Approved 1987
TERAZOSIN
CHEMBL611
Approved 1987
FLUOXETINE
CHEMBL41
Approved 1987
GUANFACINE
CHEMBL862
Approved 1986
OXYMETAZOLINE
CHEMBL762
Approved 1986
ASCORBIC ACID
CHEMBL196
Approved 1985
HALOPROGIN
CHEMBL1289
Approved 1982
GUANABENZ
CHEMBL420
Approved 1982
GENTIAN VIOLET
CHEMBL64894
Approved 1982
TRAZODONE
CHEMBL621
Approved 1981
AMOXAPINE
CHEMBL1113
Approved 1980
MAPROTILINE
CHEMBL21731
Approved 1980
BROMOCRIPTINE
CHEMBL493
Approved 1978
CLEMASTINE
CHEMBL1626
Approved 1977
PRAZOSIN
CHEMBL2
Approved 1976
PRAZOSIN HYDROCHLORIDE
CHEMBL1558
Approved 1976
CLONIDINE
CHEMBL134
Approved 1974
CLONIDINE HYDROCHLORIDE
CHEMBL1705
Approved 1974
DROPERIDOL
CHEMBL1108
Approved 1970
Assay Landscape

Assay Landscape

325
Total Assays
640
Tested Compounds
4
Assay Types
Binding — 261 assays, 640 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 187 250 6.3
cell-based format 70 277 6.7
cell membrane format 2 104 6.5
assay format 1 1 8.1
organism-based format 1 8 6.3
Functional — 57 assays, 123 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 36 107 6.4
assay format 20 15 7.1
cell membrane format 1 1 6.9
ADME — 5 assays, 2 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 5 2 6.9
Unassigned — 2 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 2 1 5.6

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine